🚨 $MRNA EXPLODES 118% AS INSTITUTIONS PRICE IN A $240B CANCER THERAPEUTIC MARKET! 💥
Smart money aggressively repriced $MRNA following a massive 118.5% expansion driven by landmark oncology trial results alongside Merck. 🦈 This structural shift redefines the baseline valuation model, unlocking access to an estimated $240 billion addressable market.
From an order flow perspective, explosive expansion of this magnitude leaves vast liquidity pools and structural inefficiencies in its wake. 📊 Market participants should monitor how higher-timeframe structure digests this volatility before looking for sustained continuation.
💡 Will institutional buyers defend this elevated price range, or are we bound to see an inefficiency fill back toward the breakout origin? 👇
⚠️ Not financial advice. Always manage your risk. 🛡️
🏷️ #MRNA #MarketStructure #Breakout #Biotech #Trading
⚡ 💎
Smart money aggressively repriced $MRNA following a massive 118.5% expansion driven by landmark oncology trial results alongside Merck. 🦈 This structural shift redefines the baseline valuation model, unlocking access to an estimated $240 billion addressable market.
From an order flow perspective, explosive expansion of this magnitude leaves vast liquidity pools and structural inefficiencies in its wake. 📊 Market participants should monitor how higher-timeframe structure digests this volatility before looking for sustained continuation.
💡 Will institutional buyers defend this elevated price range, or are we bound to see an inefficiency fill back toward the breakout origin? 👇
⚠️ Not financial advice. Always manage your risk. 🛡️
🏷️ #MRNA #MarketStructure #Breakout #Biotech #Trading
⚡ 💎